Literature DB >> 8418788

Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5.

A I Bartholomeusz1, P J Wright.   

Abstract

An assay for flavivirus RNA-dependent RNA polymerase activity in vitro was established using extracts of Vero cells infected with dengue virus type 2 (DEN-2) or Kunjin virus (KUN). RNA synthesis was initiated on a template of viral replicative form (RF) and RF was converted to the replicative intermediate (RI). The RNA-dependent RNA polymerase complex of DEN-2 utilised either DEN-2 or KUN RF as template, and similarly the KUN polymerase complex utilised either DEN-2 or KUN RF template. In addition, antibodies against the nonstructural proteins NS3 and NS5 inhibited the conversion of RF to RI, indicating that NS3 and NS5 are involved in viral RNA replication.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418788     DOI: 10.1007/bf01309792

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  34 in total

1.  Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses.

Authors:  J F Bazan; R J Fletterick
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

2.  Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses.

Authors:  Y S Hahn; R Galler; T Hunkapiller; J M Dalrymple; J H Strauss; E G Strauss
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

3.  Analysis of structural properties which possibly are characteristic for the 3'-terminal sequence of the genome RNA of flaviviruses.

Authors:  G Wengler; E Castle
Journal:  J Gen Virol       Date:  1986-06       Impact factor: 3.891

4.  Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication.

Authors:  P W Chu; E G Westaway
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

5.  Dissociation of NS5 from cell fractions containing West Nile virus-specific polymerase activity.

Authors:  J B Grun; M A Brinton
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

6.  Involvement of the host cell nuclear envelope membranes in the replication of Japanese encephalitis virus.

Authors:  E Zebovitz; J K Leong; S C Doughty
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

7.  Synthesis of proteins and glycoproteins in dengue type 2 virus-infected vero and Aedes albopictus cells.

Authors:  G W Smith; P J Wright
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891

8.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Identification and characterization of type 2 dengue virus replicative intermediate and replicative form RNAs.

Authors:  G R Cleaves; T E Ryan; R W Schlesinger
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

10.  Comparisons of togaviruses: Sindbis virus (group A) and Kunjin virus (group B).

Authors:  R W Boulton; E G Westaway
Journal:  Virology       Date:  1972-07       Impact factor: 3.616

View more
  29 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 2.  Flavivirus RNA synthesis in vitro.

Authors:  Radhakrishnan Padmanabhan; Ratree Takhampunya; Tadahisa Teramoto; Kyung H Choi
Journal:  Methods       Date:  2015-08-10       Impact factor: 3.608

3.  Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution.

Authors:  Thai Leong Yap; Ting Xu; Yen-Liang Chen; Helene Malet; Marie-Pierre Egloff; Bruno Canard; Subhash G Vasudevan; Julien Lescar
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

4.  Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.

Authors:  Eloise Mastrangelo; Margherita Pezzullo; Tine De Burghgraeve; Suzanne Kaptein; Boris Pastorino; Kai Dallmeier; Xavier de Lamballerie; Johan Neyts; Alicia M Hanson; David N Frick; Martino Bolognesi; Mario Milani
Journal:  J Antimicrob Chemother       Date:  2012-04-25       Impact factor: 5.790

5.  CRM1-mediated nuclear export of dengue virus RNA polymerase NS5 modulates interleukin-8 induction and virus production.

Authors:  Stephen M Rawlinson; Melinda J Pryor; Peter J Wright; David A Jans
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

6.  Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes.

Authors:  Kathryn A Hanley; Jay J Lee; Joseph E Blaney; Brian R Murphy; Stephen S Whitehead
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 7.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

8.  Significance in replication of the terminal nucleotides of the flavivirus genome.

Authors:  Alexander A Khromykh; Natasha Kondratieva; Jean-Yves Sgro; Ann Palmenberg; Edwin G Westaway
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication.

Authors:  Moon Y F Tay; Wuan Geok Saw; Yongqian Zhao; Kitti W K Chan; Daljit Singh; Yuwen Chong; Jade K Forwood; Eng Eong Ooi; Gerhard Grüber; Julien Lescar; Dahai Luo; Subhash G Vasudevan
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

10.  Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys.

Authors:  R Men; M Bray; D Clark; R M Chanock; C J Lai
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.